This page has been updated recently.
- March 24, 2017 Approval Letter - Prevnar 13 (PDF - 32KB)
Posted: 3/27/2017 - FDA assay predicts ability of mesenchymal stromal cells to suppress immune system activity
Posted: 3/27/2017 - Office of Tissues And Advanced Therapies (OTAT): Medical Officer (Hematology)
Posted: 3/27/17
.png)
No hay comentarios:
Publicar un comentario